
GlucoTrack Investor Relations Material
Latest events

Q1 2025
14 May, 2025

Q4 2024
31 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from GlucoTrack Inc
Access all reports
GlucoTrack, Inc. is a medical device company focused on developing and commercializing innovative technologies designed for people with diabetes. The company’s flagship product, also named GlucoTrack, is a non-invasive glucose monitoring device that allows users to obtain blood glucose readings without the need for fingersticks or other invasive procedures. Additionally, GlucoTrack is working on a long-term implantable continuous blood glucose monitor (CBGM) aimed at providing accurate, continuous glucose monitoring for extended periods, addressing challenges such as calibration and comfort found in traditional CGM systems. GlucoTrack, Inc. is headquartered in Rutherford, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
Ticker symbol
GCTK
Country
🇺🇸 United States